Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019
Thursday, February 6th 2020 at 9:00pm UTC Webcast and Conference Call Today at 4:30 p.m. ET Positive results from part…
Thursday, February 6th 2020 at 9:00pm UTC Webcast and Conference Call Today at 4:30 p.m. ET Positive results from part…
Wednesday, July 8th 2020 at 11:00am UTC LITTLETON, Mass.–(BUSINESS WIRE)– Mevion Medical Systems announced today that patient treatment has commenced…
Wednesday, July 8th 2020 at 1:44pm UTC Cohorts of younger adults (n=300) and older adults (n=300) in Phase 2 study…
Wednesday, July 8th 2020 at 11:00am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company…
Wednesday, July 8th 2020 at 11:00am UTC BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)– Talaris Therapeutics, Inc., a privately held biotechnology company…
Monday, January 27th 2020 at 9:01pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field…
Wednesday, November 13th 2019 at 12:30pm UTC – KVD900 Phase 2 Clinical Trial for Treatment of Hereditary Angioedema (HAE) Expected…
Thursday, December 19th 2019 at 2:00pm UTC Technology to significantly improve outcomes for autoimmune disease patients by ensuring optimal therapy…
Friday, May 15th 2020 at 8:43pm UTC -QINLOCK Significantly Improved Progression-Free Survival and Showed Clinically Meaningful Overall Survival in INVICTUS…
Monday, June 22nd 2020 at 10:00am UTC LITTLETON, Mass.–(BUSINESS WIRE)– Today, Mevion Medical Systems and Orfit Industries are pleased to…